Corrigendum: The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia

Corrigendum: The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia

Show other versions (1)

Bibliographic Details
Main Authors:	Xing-Jie Peng, Gang-Rui Hei, Ye Yang, Chen-Chen Liu, Jing-Mei Xiao, Yu-Jun Long, Jing Huang, Jing-Ping Zhao, Ren-Rong Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Psychiatry
Subjects:	cognitive impairment first episode drug-naïve schizophrenia MCCB correlation analysis positive and negative symptoms
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2021.678836/full

Similar Items

Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia
by: Xing-Jie Peng, et al.
Published: (2022-12-01)

The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
by: Xing-Jie Peng, et al.
Published: (2021-02-01)

Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia
by: Na Zhao, et al.
Published: (2021-04-01)

Relationships between abnormal neural activities and cognitive impairments in patients with drug-naive first-episode schizophrenia
by: Wei Yan, et al.
Published: (2020-06-01)

Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition
by: Verónica Romero-Ferreiro, et al.
Published: (2022-04-01)

Corrigendum: The association between metabolic disturbance and cognitive impairments in early-stage schizophrenia
by: Xing-Jie Peng, et al.
Published: (2022-11-01)

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
by: Qianqian Wei, et al.
Published: (2022-02-01)

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia
by: Qiaoling Sun, et al.
Published: (2022-03-01)

Impaired Binocular Depth Perception in First-Episode Drug-Naive Patients With Schizophrenia
by: Zhengchun Wang, et al.
Published: (2018-05-01)

Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis
by: Fang Dong, et al.
Published: (2023-12-01)

The Association Between Metabolic Disturbance and Cognitive Impairments in Early-Stage Schizophrenia
by: Xing-Jie Peng, et al.
Published: (2021-02-01)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
by: Zhang Cheng, et al.
Published: (2020-06-01)

The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia
by: Katarzyna Rek-Owodziń, et al.
Published: (2022-05-01)

Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia
by: Yan-Bing Xiong, et al.
Published: (2019-03-01)

Core of sensory gating deficits in first-episode schizophrenia: attention dysfunction
by: Yushen Ding, et al.
Published: (2023-04-01)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
by: Zhuo K, et al.
Published: (2019-05-01)

Altered functional connectivity of cerebellar networks in first-episode schizophrenia
by: Sitong Feng, et al.
Published: (2022-11-01)

Amplitude of low-frequency fluctuation (ALFF) may be associated with cognitive impairment in schizophrenia: a correlation study
by: Pengshuo Wang, et al.
Published: (2019-01-01)

Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients
by: Xiang Zhou, et al.
Published: (2020-07-01)

Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients
by: Helle G. Andersen, et al.
Published: (2020-05-01)

Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia
by: Manli Huang, et al.
Published: (2016-10-01)

Cognitive Dysfunctions Measured with the MCCB in Deficit and Non-Deficit Schizophrenia
by: Piotr Plichta, et al.
Published: (2023-03-01)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
by: Gloria Giordano, et al.
Published: (2020-01-01)

Prediction of drop-out and functional impairment in recent-onset schizophrenia spectrum disorders
by: A. Mucci, et al.
Published: (2021-04-01)

The importance of blood count and oxidative stress in the drug-naïve first episode schizophrenia
by: J. Rog, et al.
Published: (2022-06-01)

Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia
by: Yuxuan Wu, et al.
Published: (2022-06-01)

Association of Subclinical Hypothyroidism With Anxiety Symptom in Young First-Episode and Drug-Naïve Patients With Major Depressive Disorder
by: Ruchang Yang, et al.
Published: (2022-06-01)

Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode Schizophrenia
by: Seon-Hwa Baek, et al.
Published: (2022-07-01)

Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study
by: Xiaoe Lang, et al.
Published: (2023-07-01)

First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort
by: Nobuhisa Kanahara, et al.
Published: (2018-09-01)

Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients
by: Miloš Marković, et al.
Published: (2023-12-01)

Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
by: Ryan Sai-Ting Chu, et al.
Published: (2021-10-01)

Case study of first episode schizophrenia
by: Shinu K. Kuriakose
Published: (2020-12-01)

Hair cortisol in drug-naïve first-episode individuals with psychosis
by: Elvis H. Andrade, et al.
Published: (2016-03-01)

Reductions in Complex Mismatch Negativity to Extra Tone Gestalt Pattern Deviance in First-Episode Schizophrenia
by: Dean F. Salisbury, et al.
Published: (2020-06-01)

Neurocognitive deficit in patients with schizophrenia
by: A. B. Shmukler, et al.
Published: (2014-01-01)

Volumetric Deficit Within the Fronto-Limbic-Striatal Circuit in First-Episode Drug Naïve Patients With Major Depression Disorder
by: Yiran Zhang, et al.
Published: (2021-01-01)

The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors
by: Shengyun Chen, et al.
Published: (2021-06-01)

Neuroanatomical differences between first-episode psychosis patients with and without neurocognitive deficit: a 3 year longitudinal study
by: Rosa eAyesa-Arriola, et al.
Published: (2013-10-01)

The Category Fluency Test components and their association with cognition and symptoms in adolescents with schizophrenia
by: Rogelio Apiquian, et al.
Published: (2024-03-01)